Intensive therapy with peripheral stem cell transplantation in 16 patients with mantle cell lymphoma.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Annals of Oncology

• Publication date

  1997-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1023/A:1008278605751PMID 9296227
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Myeloablative therapy with blood stem cell transplantation is effective in mantle cell lymphoma.

  1996cited by this paper
• Mantle-cell lymphoma: a population-based clinical study.

  1996cited by this paper
• Patterns of survival in mantle cell lymphoma.

  1995cited by this paper
• Efficacy of four different regimens in 64 mantle-cell lymphoma cases: clinicopathologic comparison with 498 other non-Hodgkin's lymphoma subtypes. European Organization for the Research and Treatment of Cancer Lymphoma Cooperative Group.

  1995cited by this paper
• The role of high-dose therapy and autologous hematopoietic stem cell transplantation for mantle cell lymphoma.

  1995cited by this paper
• Mantle cell lymphoma: a therapeutic dilemma.

  1995cited by this paper
• A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group.

  1994cited by this paper
• Nonfollicular small B-cell lymphomas: a heterogeneous group of patients with distinct clinical features and outcome.

  1994cited by this paper
• European Lymphoma Task Force (ELTF): Report of the workshop on Mantle Cell Lymphoma (MCL)

  1994cited by this paper
• A predictive model for aggressive non-Hodgkin's lymphoma.

  1993cited by this paper
• Prognostic factors in non-Hodgkin's lymphoma.

  1992cited by this paper
• Mantle cell lymphoma. A proposal for unification of morphologic, immunologic, and molecular data.

  1992cited by this paper
• PRAD1, a candidate BCL1 oncogene: mapping and expression in centrocytic lymphoma.

  1991cited by this paper
• Lymphocytic lymphoma of intermediate differentiation: morphologic, immunophenotypic, and prognostic factors.

  1990cited by this paper
• Multicentre randomized therapeutic trial for advanced centrocytic lymphoma: Anthracycline does not improve the prognosis

  1989cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper

• Paramount therapy for young and fit patients with mantle cell lymphoma: strategies for front-line therapy

  2018cites this paper
• Case Study: Rare Case of Mantle Cell Lymphoma With Extranodal Involvement in the Foot.

  2017cites this paper
• Granulopoiesis‐stimulating factors for preventing infections after autologous peripheral stem cell transplantation for lymphoma and multiple myeloma in adults

  2016cites this paper
• Mantle cell lymphoma: observation to transplantation

  2015cites this paper
• cyclin D1-negative MCL-like B-cell lymphoma lymphoma: a clinicopathologic comparison of cyclin D1-positive MCL and Significance of cyclin D1 overexpression for the diagnosis of mantle cell

  2013cites this paper
• Reappraising the role of autologous transplantation for indolent B-cell lymphomas in the chemoimmunotherapy era: is it still relevant?

  2013cites this paper
• Rituximab purging and/or maintenance in patients undergoing autologous transplantation for relapsed follicular lymphoma: a prospective randomized trial from the lymphoma working party of the European group for blood and marrow transplantation.

  2013cites this paper
• Current Management of Mantle Cell Lymphoma

  2012cites this paper
• Hematopoietic cell transplantation for B-cell lymphoma: an update.

  2012cites this paper
• Diffuse Large B-Cell Lymphoma Autologous Transplantation

  2011cites this paper
• Does more intensive therapy have effects on mantle cell lymphoma? A clinical experience from the Lymphoma Treatment Study Group in Japan

  2011cites this paper
• Hematopoietic cell transplantation for lymphomas.

  2011cites this paper
• Hematopoietic SCT for mantle cell lymphoma: is it the standard of care?

  2010cites this paper
• Phase II trial and prediction of response of single agent tipifarnib in patients with relapsed/refractory mantle cell lymphoma: a Groupe d’Etude des Lymphomes de l’Adulte trial

  2010cites this paper
• Role of chemotherapy in gastric MALT lymphoma, diffuse large B-cell lymphoma and other lymphomas.

  2010cites this paper
• Progress in mantle-cell lymphoma.

  2009cites this paper
• Mantle cell lymphoma: state-of-the-art management and future perspective

  2009cites this paper
• Rituximab purging and maintenance combined with auto-SCT: long-term molecular remissions and prolonged hypogammaglobulinemia in relapsed follicular lymphoma

  2009cites this paper
• Effect of remission status and induction chemotherapy regimen on outcome of autologous stem cell transplantation for mantle cell lymphoma

  2008cites this paper
• Stem Cell Transplantation for Hodgkin's and Non-Hodgkin's Lymphomas

  2008cites this paper
• Farnesyltransferase inhibitor R115777 inhibits cell growth and induces apoptosis in mantle cell lymphoma

  2008cites this paper
• Blood or marrow transplantation for mantle cell lymphoma

  2007cites this paper
• Blood and bone marrow transplantation for patients with Hodgkin's and non-Hodgkin's lymphoma.

  2006cites this paper
• Treatment of mantle cell lymphoma: current approach and future directions.

  2006cites this paper
• Mantelzell-Lymphom (zentrozytisches Lymphom)

  2006cites this paper
• Chłoniak z komórek płaszcza - współczesne możliwości lecznicze

  2005cites this paper
• Outcomes of autologous and allogeneic blood or marrow transplantation for mantle cell lymphoma.

  2005cites this paper
• Chemotherapy with rituximab followed by high‐dose therapy and autologous stem cell transplantation in patients with mantle cell lymphoma

  2005cites this paper
• Long-term event-free survivors after high-dose therapy and autologous stem-cell transplantation for low-grade follicular lymphoma

  2005cites this paper
• prospective randomized trial of the European MCL Network prolongs progression-free survival in mantle-cell lymphoma : results of a autologous stem cell transplantation in first remission significantly Early consolidation by myeloablative radiochemotherapy followed

  2005cites this paper
• Stem cell transplantation for mantle cell lymphoma: if, when and how?

  2005cites this paper
• An update on the role of high-dose therapy with autologous or allogeneic stem cell transplantation in mantle cell lymphoma

  2004cites this paper
• Intensive chemotherapy and autologous stem-cell transplantation plus rituximab is superior to conventional chemotherapy for newly diagnosed advanced stage mantle-cell lymphoma: a matched pair analysis.

  2004cites this paper
• High Level of Glutathione-S-Transferase π Expression in Mantle Cell Lymphomas

  2004cites this paper
• Early consolidation by myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission significantly prolongs progression-free survival in mantle-cell lymphoma: results of a prospective randomized trial of the European MCL Network.

  2004cites this paper
• Lymphome du manteau: un modèle biologique et clinique

  2004cites this paper
• Reduced-intensity rituximab-BEAM-CAMPATH allogeneic haematopoietic stem cell transplantation for follicular lymphoma is feasible and induces durable molecular remissions

  2003cites this paper
• Long‐term follow‐up of autologous stem cell transplantation in patients with diffuse mantle cell lymphoma in first disease remission

  2003influential citation
• Outcome of autologous transplantation for mantle cell lymphoma: a study by the European Blood and Bone Marrow Transplant and Autologous Blood and Marrow Transplant Registries

  2003cites this paper
• Mantle cell lymphoma: clinicopathologic features and treatments.

  2003cites this paper
• Current role and future perspectives for ifosfamide in the treatment of malignant non-Hodgkin's lymphoma--results from an expert meeting.

  2003cites this paper
• Autologous hematopoietic cell transplantation for non-Hodgkin's lymphoma: 100 month follow-up

  2002cites this paper
• High-dose ara-C with autologous peripheral blood progenitor cell support induces a marked progenitor cell mobilization: an indication for patients at risk for low mobilization

  2002cites this paper
• In vivo purging and relapse prevention following ASCT

  2002cites this paper
• Immunotherapy with rituximab following high-dose therapy and autologous stem-cell transplantation for mantle cell lymphoma.

  2002cites this paper
• Mantle Cell Lymphoma : Clinicopathological Features and Prognostic Factors

  2002cites this paper
• Autologous and allogeneic transplantation for aggressive NHL.

  2002cites this paper
• Mantle cell lymphoma: new treatments targeted to the biology.

  2002cites this paper
• Mantle Cell Lymphoma: A Biological and Therapeutic Paradigm

  2002cites this paper
• Seventy-Two Hour Continuous Infusion Flavopiridol in Relapsed and Refractory Mantle Cell Lymphoma

  2002cites this paper
• Autologous Stem Cell Transplantation in Patients with Mantle Cell Lymphoma

  2002cites this paper
• Autologous hematopoietic transplantation for low-grade lymphomas.

  2002cites this paper
• Rituximab and CHOP induction therapy for newly diagnosed mantle-cell lymphoma: molecular complete responses are not predictive of progression-free survival.

  2002cites this paper
• Immunotherapy with rituximab following high-dose therapy and autologous stem-cell transplantation for mantle cell lymphoma.

  2002cites this paper
• Concurrent administration of high-dose chemotherapy and rituximab is a feasible and effective chemo/immunotherapy for patients with high-risk non-Hodgkin's lymphoma

  2001cites this paper
• Blastic variant of mantle cell lymphoma: a rare but highly aggressive subtype

  2001cites this paper
• Clinical relevance of minimal residual disease monitoring in mature B-cell disorders: role of qualitative and quantitative PCR-based strategies

  2001cites this paper
• Stem cell transplantation for mantle cell lymphoma: should it ever be used outside clinical trials?

  2001cites this paper
• High-dose therapy in lymphomas: a review of the current status of allogeneic and autologous stem cell transplantation in Hodgkin's disease and non-Hodgkin's lymphoma.

  2001cites this paper
• Mantle-cell lymphoma.

  2001cites this paper
• High-dose mitoxantrone + melphalan (MITO/L-PAM) as conditioning regimen supported by peripheral blood progenitor cell (PBPC) autograft in 113 lymphoma patients: high tolerability with reversible cardiotoxicity

  2001cites this paper
• Allogeneic stem cell transplantation for the non-Hodgkin's lymphomas and Hodgkin's disease.

  2000cites this paper
• European phase II study of rituximab (chimeric anti-CD20 monoclonal antibody) for patients with newly diagnosed mantle-cell lymphoma and previously treated mantle-cell lymphoma, immunocytoma, and small B-cell lymphocytic lymphoma.

  2000cites this paper
• Prognostic factors for the clinical outcome of patients with follicular lymphoma following high-dose therapy and peripheral blood stem cell transplantation (PBSCT)

  2000cites this paper
• High-Dose Therapy With Autologous Bone Marrow Support as Consol idat ion of Remiss ion in Fol l icular Lymphoma : Long-Term Clinica l and Molecular Fol low-Up

  2000cites this paper
• High-dose therapy with autologous stem-cell transplantation (ASCT) after first progression prolonged survival of follicular lymphoma patients included in the prospective GELF 86 protocol.

  2000cites this paper
• Significance of cyclin D1 overexpression for the diagnosis of mantle cell lymphoma: a clinicopathologic comparison of cyclin D1-positive MCL and cyclin D1-negative MCL-like B-cell lymphoma.

  2000cites this paper
• Autotransplantation following busulfan, etoposide and cyclophosphamide in patients with non-Hodgkin's lymphoma

  2000cites this paper
• Autologous stem cell transplantation (ASCT) with immunologically purged progenitor cells in patients with advanced stage follicular lymphoma after early partial or complete remission: toxicity, follow-up of minimal residual disease and survival

  2000cites this paper
• Monoclonal antibodies recognizing CD5, CD10 and CD23 in formalin‐fixed, paraffin‐embedded tissue: production and assessment of their value in the diagnosis of small B‐cell lymphoma

  2000cites this paper
• Autologous hematopoietic stem cell transplantation for mantle cell lymphoma.

  2000cites this paper
• Efficacy of autologous stem cell transplantation in mantle cell lymphoma: a 3-year follow-up study

  2000cites this paper
• Hematopoietic Stem Cell Transplantation for Mantle Cell Lymphoma

  2000cites this paper
• Value of autologous stem cell transplantation with purged bone marrow as first-line therapy for follicular lymphoma with high tumor burden: a GOELAMS phase II study

  2000cites this paper
• Brief Report Dexa-BEAM: An Effective Regimen for Cytoreduction Prior to High-Dose Chemotherapy with Autologous Stem Cell Support for Patients with Relapsed/Refractory Mantle-Cell Lymphema

  2000cites this paper
• Dexa-BEAM: an effective regimen for cytoreduction prior to high-dose chemotherapy with autologous stem cell support for patients with relapsed/refractory mantle-cell lymphoma.

  2000cites this paper
• Mantle cell lymphoma. A clinicopathologic study of 68 cases from the Nebraska Lymphoma Study Group

  2000cites this paper
• Overweight as an adverse prognostic factor for non-Hodgkin's lymphoma patients receiving high-dose chemotherapy and autograft

  2000cites this paper
• Indolent nonfollicular lymphomas: characteristics, treatment, and outcome.

  1999cites this paper
• Clinical relevance of minimal residual disease monitoring in non-Hodgkin’s lymphomas: a critical reappraisal of molecular strategies

  1999cites this paper
• Autologous hematopoietic cell transplantation in non-Hodgkin's lymphoma.

  1999cites this paper
• Clinical practice guidelines.

  1999cites this paper
• Peripheral blood stem cell contamination in mantle cell non-Hodgkin lymphoma: the case for purging?

  1999cites this paper
• Treatment of aggressive non-Hodgkin's lymphoma.

  1999cites this paper
• Autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma.

  1999cites this paper
• Management of mantle cell lymphoma

  1999cites this paper
• Mantle cell lymphoma in the Chinese: Clinicopathological features and treatment outcome

  1998cites this paper
• Progenitor cell yields are frequently poor in patients with histologically indolent lymphomas especially when mobilized within 6 months of previous chemotherapy

  1998cites this paper
• Evaluation and management of the "new" lymphoma entities: mantle cell lymphoma, lymphoma of mucosa-associated lymphoid tissue, anaplastic large-cell lymphoma, and primary mediastinal B-cell lymphoma.

  1998cites this paper
• Which treatment for mantle-cell lymphoma patients in 1998?

  1998cites this paper
• Mantle cell lymphoma: a retrospective study of 121 cases

  1998cites this paper
• Durability of remission after ABMT for NHL: the importance of the 2-year evaluation point

  1997cites this paper
• High-dose therapy followed by bone marrow transplantation for relapsed follicular non-hodgkin's lymphoma

  1996cites this paper